| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |